Patents by Inventor Anuradha Vaidya

Anuradha Vaidya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11819533
    Abstract: The disclosure features non-irritating pharmaceutical compositions containing CD101 in pharmaceutical acceptable salt (e.g., CD101 acetate) or neutral form. The pharmaceutical compositions can be intravenously administered to a subject to treat fungal infections (e.g., candidiasis) in the subject.
    Type: Grant
    Filed: December 1, 2021
    Date of Patent: November 21, 2023
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Kenneth Bartizal, Paul Daruwala, David Hughes, Martin Patrick Hughes, Navdeep B. Malkar, Balasingam Radhakrishnan, Anuradha Vaidya
  • Patent number: 11654196
    Abstract: The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.
    Type: Grant
    Filed: July 2, 2020
    Date of Patent: May 23, 2023
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Balasingam Radhakrishnan, Kenneth Duke James, Jr., Anuradha Vaidya, Karen Polowy
  • Publication number: 20220323539
    Abstract: The disclosure features non-irritating pharmaceutical compositions containing CD101 in pharmaceutical acceptable salt (e.g., CD101 acetate) or neutral form. The pharmaceutical compositions can be intravenously administered to a subject to treat fungal infections (e.g., candidiasis) in the subject.
    Type: Application
    Filed: December 1, 2021
    Publication date: October 13, 2022
    Inventors: Kenneth BARTIZAL, Paul DARUWALA, David HUGHES, Martin Patrick HUGHES, Navdeep B. MALKAR, Balasingam RADHAKRISHNAN, Anuradha VAIDYA
  • Patent number: 11197909
    Abstract: The disclosure features non-irritating pharmaceutical compositions containing CD101 in pharmaceutical acceptable salt (e.g., CD101 acetate) or neutral form. The pharmaceutical compositions can be intravenously administered to a subject to treat fungal infections (e.g., candidiasis) in the subject.
    Type: Grant
    Filed: July 11, 2018
    Date of Patent: December 14, 2021
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Kenneth Bartizal, Paul Daruwala, David Hughes, Martin Patrick Hughes, Navdeep B. Malkar, Balasingam Radhakrishnan, Anuradha Vaidya
  • Publication number: 20210128670
    Abstract: The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.
    Type: Application
    Filed: July 2, 2020
    Publication date: May 6, 2021
    Inventors: Balasingam RADHAKRISHNAN, Kenneth Duke JAMES, JR., Anuradha VAIDYA, Karen POLOWY
  • Publication number: 20200268833
    Abstract: The disclosure features non-irritating pharmaceutical compositions containing CD101 in pharmaceutical acceptable salt (e.g., CD101 acetate) or neutral form. The pharmaceutical compositions can be intravenously administered to a subject to treat fungal infections (e.g., candidiasis) in the subject.
    Type: Application
    Filed: July 11, 2018
    Publication date: August 27, 2020
    Inventors: Kenneth BARTIZAL, Paul DARUWALA, David HUGHES, Martin Patrick HUGHES, Navdeep B. MALKAR, Balasingam RADHAKRISHNAN, Anuradha VAIDYA
  • Patent number: 10702573
    Abstract: The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.
    Type: Grant
    Filed: June 25, 2018
    Date of Patent: July 7, 2020
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Balasingam Radhakrishnan, Kenneth Duke James, Jr., Anuradha Vaidya, Karen Polowy
  • Publication number: 20190160141
    Abstract: The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.
    Type: Application
    Filed: June 25, 2018
    Publication date: May 30, 2019
    Inventors: Balasingam RADHAKRISHNAN, Kenneth Duke JAMES, JR., Anuradha VAIDYA, Karen POLOWY
  • Patent number: 10016479
    Abstract: The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.
    Type: Grant
    Filed: December 7, 2016
    Date of Patent: July 10, 2018
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Balasingam Radhakrishnan, Kenneth Duke James, Jr., Anuradha Vaidya, Karen Polowy
  • Publication number: 20170151306
    Abstract: The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.
    Type: Application
    Filed: December 7, 2016
    Publication date: June 1, 2017
    Inventors: Balasingam RADHAKRISHNAN, Kenneth Duke JAMES, JR., Anuradha VAIDYA, Karen POLOWY
  • Patent number: 9526835
    Abstract: The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: December 27, 2016
    Assignee: Cidara Therapeutics, Inc.
    Inventors: Balasingam Radhakrishnan, Kenneth Duke James, Jr., Anuradha Vaidya, Karen Polowy
  • Patent number: 9308263
    Abstract: The invention features pharmaceutical compositions including (i) a drug, and (ii) a PEG fatty acid ester or PPG fatty acid ester in an amount sufficient to increase the oral bioavailability of the drug.
    Type: Grant
    Filed: October 19, 2012
    Date of Patent: April 12, 2016
    Assignee: Seachaid Pharmaceuticals, Inc.
    Inventors: Balasingam Radhakrishnan, Anuradha Vaidya, Navdeep Balkrishna Malkar, Karen Polowy, Kenneth Duke James, Jr.
  • Publication number: 20160074322
    Abstract: The invention features pharmaceutical compositions, methods, and kits including cefepime, or a pharmaceutically acceptable salt thereof and an additive including an acyl carnitine. The additive is present in an amount sufficient to increase the oral bioavailability of the cefepime.
    Type: Application
    Filed: April 25, 2014
    Publication date: March 17, 2016
    Inventors: Balasingam RADHAKRISHNAN, Anuradha VAIDYA
  • Publication number: 20150087583
    Abstract: The invention features pharmaceutical compositions, methods, and kits featuring dosing gimens and oral dosage formulations for administration of echinocandin class compounds.
    Type: Application
    Filed: March 14, 2013
    Publication date: March 26, 2015
    Applicant: Cidara Therapeutics, Inc.
    Inventors: Balasingam Radhakrishnan, Kenneth Duke James, JR., Anuradha Vaidya, Karen Polowy
  • Publication number: 20140329793
    Abstract: The invention features pharmaceutical compositions including (i) a drug, and (ii) a PEG fatty acid ester or PPG fatty acid ester in an amount sufficient to increase the oral bioavailability of the drug.
    Type: Application
    Filed: October 19, 2012
    Publication date: November 6, 2014
    Applicant: SEACHAID PHARMACEUTICALS, INC.
    Inventors: Balasingam Radhakrishnan, Anuradha Vaidya, Navdeep Balkrishna Malkar, Karen Polowy, Kenneth Duke James, JR.